Detailed Narrative
Top-line Growth Remains Robust Despite Accounting Headwinds
Niva Bupa reported strong underlying business momentum with a like-for-like Gross Written Premium (GWP) growth of 28% in Q1 FY26. The growth was spearheaded by the retail health segment, which grew by 32%. However, management repeatedly cautioned that the reported Indian GAAP financials are 'distorted' due to the new 1/n accounting rule for multi-year policies and that this 'noise' is expected to continue for 2-3 years. They strongly urged analysts to focus on the IFRS financials, which they believe provide a truer picture of the company's performance.
IFRS Profitability Doubles, But Loss Ratio Ticks Up
On an IFRS basis, Profit After Tax (PAT) nearly doubled to ₹70 crores from ₹36 crores in the same quarter last year. The IFRS combined ratio saw a modest improvement of 70 basis points to 103.2%, primarily driven by better expense management. Despite this, the underlying IFRS loss ratio increased year-over-year, with the retail loss ratio moving to 68% from 66% and the group loss ratio increasing to 61% from 58%, a trend attributed to higher reserving and a change in business mix.
Claims Auto-Adjudication Halt Pressures SLAs and Reserves
A significant operational issue occurred in Q1, where the company had to suspend its claims auto-adjudication service due to information security reviews with third parties. This directly impacted service levels, with the rate of cashless approvals within 30 minutes falling from a typical 90% to 76%. The suspension also led to a buildup in outstanding claims, compelling the company to prudently increase its reserves, which management quantified as having a 1.5% to 2% adverse impact on the quarter's loss ratio. The service was reportedly restored in July 2025.
Market Share Gains and Strategic Shift Away from Multi-Year Policies
The company continued to gain traction in its core segment, with retail market share inching up to 10% from 9.9% a year ago. In a notable strategic disclosure, management revealed they are actively reducing the share of multi-year policies in their business mix, from the 'late 20s' percentage-wise down to the 'early 20s'. This move could help reduce accounting volatility but may impact GWP growth. To manage profitability, the company also executed a 7% price hike on its flagship product, ReAssure 2.0, during the quarter.
Operating Leverage Drives EOM Ratio Improvement
Niva Bupa demonstrated strong cost control and operating leverage in the quarter. The Expense of Management (EOM) ratio improved significantly to 35.9% from 40.7% in Q1 FY25. Management attributed this to GWP growing 28% while operating expenses grew only in the low-single digits. The company's financial stability remains strong, with a healthy solvency ratio of 2.86x, comfortably above the regulatory requirement of 1.50x.
Health App Metrics Show Strong Customer Engagement
Reinforcing its strategy to be a 'health partner', Niva Bupa highlighted strong engagement on its digital platform. The health app has reached 12.3 million downloads with 5.7 lakh monthly active users. The platform facilitates over 50,000 health checkups and 6,000 doctor consultations monthly. In Q1, the company launched a new chronic condition management program on the app, aiming to proactively manage lifestyle diseases and bend the long-term cost curve on claims.